CIAM
CABA icon

Caitong International Asset Management’s Cabaletta Bio CABA Stock Holding History

Caitong International Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.56K Buy
+1,322
New +$3.67K ﹤0.01% 1165
2025
Q4 		– Sell
-8,983
Closed -$21K – 1928
2025
Q3 		$21K Buy
+8,983
New +$15.4K 0.01% 679
2025
Q2 		– Sell
-1,409
Closed -$1.95K – 2035
2025
Q1 		$1.95K Buy
+1,409
New +$3K ﹤0.01% 1360

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Caitong International Asset Management's CABA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Cabaletta Bio (CABA) in Q1 2026: 1,322 shares worth $3.56K. The stake represents ﹤0.01% of the portfolio and ranks #1165 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in CABA as recently as Q3 2025.

Caitong International Asset Management first reported a position in CABA in Q1 2025 and has held it in 3 quarters since. The position peaked at $21K in Q3 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Caitong International Asset Management held 1,322 shares of Cabaletta Bio worth $3.56K as of Q1 2026.
  • Cabaletta Bio was a new Caitong International Asset Management position in Q1 2026.
  • Cabaletta Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1165 holding.
  • Caitong International Asset Management first reported a position in Cabaletta Bio in Q1 2025 and has held it in 3 quarters since.
  • Caitong International Asset Management's Cabaletta Bio position peaked at $21K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.